An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)

Plasma-derived product

A medicine or biological product that is made using human whole blood or plasma.

Manufacturer discount program

A program under Medicare Part D where drug manufacturers provide discounts on certain prescription drugs, especially when a beneficiary reaches high out-of-pocket spending.

Applicable beneficiary

A person enrolled in a Medicare Part D prescription drug plan who qualifies for the manufacturer discount program, typically due to high drug costs.

Negotiated price

The price a pharmacy (or other dispenser) and a drug plan have agreed upon for a specific drug, before any discounts or patient cost-sharing are applied.

Out-of-pocket threshold

The maximum amount of money a Medicare Part D beneficiary must pay for their prescription drugs in a year before they enter the catastrophic coverage phase, where their costs are significantly reduced.

Catastrophic coverage phase

A stage in the Medicare Part D prescription drug program that beneficiaries enter after their out-of-pocket drug costs for the year reach a certain amount, leading to much lower personal costs for remaining prescriptions.